{"id":"https://openalex.org/W4313199044","doi":"https://doi.org/10.1254/jpssuppl.96.0_3-b-p-232","title":"p-Hydroxyamphetamine induced prepulse inhibition disruptions is modulated by serotonergic and adrenergic receptors","display_name":"p-Hydroxyamphetamine induced prepulse inhibition disruptions is modulated by serotonergic and adrenergic receptors","publication_year":2022,"publication_date":"2022-01-01","ids":{"openalex":"https://openalex.org/W4313199044","doi":"https://doi.org/10.1254/jpssuppl.96.0_3-b-p-232"},"language":"en","primary_location":{"id":"doi:10.1254/jpssuppl.96.0_3-b-p-232","doi":"https://doi.org/10.1254/jpssuppl.96.0_3-b-p-232","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jpssuppl.96.0_3-b-p-232","pdf_url":"https://www.jstage.jst.go.jp/article/jpssuppl/96/0/96_3-B-P-232/_pdf","source":{"id":"https://openalex.org/S4210239061","display_name":"Proceedings for Annual Meeting of The Japanese Pharmacological Society","issn_l":"2435-4953","issn":["2435-4953"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceedings for Annual Meeting of The Japanese Pharmacological Society","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.jstage.jst.go.jp/article/jpssuppl/96/0/96_3-B-P-232/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062781620","display_name":"Hiroshi Onogi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111288359","display_name":"Tohoku Fukushi University","ror":"https://ror.org/01qr5a671","country_code":"JP","type":"education","lineage":["https://openalex.org/I111288359"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroshi Onogi","raw_affiliation_strings":["Dept. Nursing, Fac. Health Sci., Tohoku Fukushi Univ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. Nursing, Fac. Health Sci., Tohoku Fukushi Univ","institution_ids":["https://openalex.org/I111288359"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071723215","display_name":"Oamu Nakagawasai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I85324120","display_name":"Tohoku Medical and Pharmaceutical University","ror":"https://ror.org/0264zxa45","country_code":"JP","type":"education","lineage":["https://openalex.org/I85324120"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Oamu Nakagawasai","raw_affiliation_strings":["Div. Pharmacol., Fac. Pharmaceut. Sci., Tohoku Med. Pharmaceut. Univ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Div. Pharmacol., Fac. Pharmaceut. Sci., Tohoku Med. Pharmaceut. Univ","institution_ids":["https://openalex.org/I85324120"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004768525","display_name":"Wataru Nemoto","orcid":"https://orcid.org/0000-0003-1253-5523","observed_orcids":["https://orcid.org/0000-0003-1253-5523"]},"institutions":[{"id":"https://openalex.org/I85324120","display_name":"Tohoku Medical and Pharmaceutical University","ror":"https://ror.org/0264zxa45","country_code":"JP","type":"education","lineage":["https://openalex.org/I85324120"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Wataru Nemoto","raw_affiliation_strings":["Div. Pharmacol., Fac. Pharmaceut. Sci., Tohoku Med. Pharmaceut. Univ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Div. Pharmacol., Fac. Pharmaceut. Sci., Tohoku Med. Pharmaceut. Univ","institution_ids":["https://openalex.org/I85324120"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004142154","display_name":"Satoru Mitazaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I25859482","display_name":"Takasaki University of Health and Welfare","ror":"https://ror.org/00n3e1d98","country_code":"JP","type":"education","lineage":["https://openalex.org/I25859482"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Satoru Mitazaki","raw_affiliation_strings":["Lab. Mol. Neurosci., Fac. Pharm., Takasaki Univ. Health and Welf"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lab. Mol. Neurosci., Fac. Pharm., Takasaki Univ. Health and Welf","institution_ids":["https://openalex.org/I25859482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049438575","display_name":"Koichi Tan\u2013No","orcid":"https://orcid.org/0000-0001-6724-848X","observed_orcids":["https://orcid.org/0000-0001-6724-848X"]},"institutions":[{"id":"https://openalex.org/I85324120","display_name":"Tohoku Medical and Pharmaceutical University","ror":"https://ror.org/0264zxa45","country_code":"JP","type":"education","lineage":["https://openalex.org/I85324120"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Koichi Tan-No","raw_affiliation_strings":["Div. Pharmacol., Fac. Pharmaceut. Sci., Tohoku Med. Pharmaceut. Univ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Div. Pharmacol., Fac. Pharmaceut. Sci., Tohoku Med. Pharmaceut. Univ","institution_ids":["https://openalex.org/I85324120"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112688384","display_name":"Takeshi Tadano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I10091056","display_name":"Kanazawa University","ror":"https://ror.org/02hwp6a56","country_code":"JP","type":"education","lineage":["https://openalex.org/I10091056"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takeshi Tadano","raw_affiliation_strings":["Dept. Environ. Prev. Med., Sch. Med. Pharmaceut. Health Sci., Kanazawa Univ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. Environ. Prev. Med., Sch. Med. Pharmaceut. Health Sci., Kanazawa Univ","institution_ids":["https://openalex.org/I10091056"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"96","issue":"0","first_page":"3","last_page":"B"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.03280000016093254,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/p-hydroxyamphetamine","display_name":"p-hydroxyamphetamine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/prepulse-inhibition","display_name":"prepulse inhibition","score":0.9350000023841858},{"id":"https://openalex.org/keywords/serotonergic-neurotransmission","display_name":"serotonergic neurotransmission","score":0.7310000061988831},{"id":"https://openalex.org/keywords/5-ht2a-receptor","display_name":"5-HT2A receptor","score":0.8960000276565552},{"id":"https://openalex.org/keywords/5-ht2c-receptor","display_name":"5-HT2C receptor","score":0.9599999785423279},{"id":"https://openalex.org/keywords/alpha1-adrenergic-receptors","display_name":"alpha1-adrenoceptors","score":0.8539999723434448},{"id":"https://openalex.org/keywords/dopaminergic-system","display_name":"dopaminergic system","score":0.7369999885559082},{"id":"https://openalex.org/keywords/ketanserin","display_name":"ketanserin","score":0.7120000123977661},{"id":"https://openalex.org/keywords/prazosin","display_name":"prazosin","score":0.7789999842643738},{"id":"https://openalex.org/keywords/5-7-dihydroxytryptamine","display_name":"5,7-dihydroxytryptamine","score":0.8769999742507935},{"id":"https://openalex.org/keywords/p-chlorophenylalanine","display_name":"p-chlorophenylalanine","score":0.8989999890327454}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7102839946746826},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6329246759414673},{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.6124318838119507},{"id":"https://openalex.org/C2777785214","wikidata":"https://www.wikidata.org/wiki/Q415997","display_name":"Ketanserin","level":5,"score":0.5983534455299377},{"id":"https://openalex.org/C200170125","wikidata":"https://www.wikidata.org/wiki/Q969316","display_name":"Neurotransmission","level":3,"score":0.5112841129302979},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.5050716996192932},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.483163058757782},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.4793625473976135},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.4713903069496155},{"id":"https://openalex.org/C2780358027","wikidata":"https://www.wikidata.org/wiki/Q407752","display_name":"Neurotoxin","level":2,"score":0.44351452589035034},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.41881343722343445},{"id":"https://openalex.org/C141421786","wikidata":"https://www.wikidata.org/wiki/Q1128897","display_name":"Prepulse inhibition","level":3,"score":0.4180281162261963},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.41187068819999695},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38513636589050293},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1759641468524933},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12058353424072266},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.0},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1254/jpssuppl.96.0_3-b-p-232","doi":"https://doi.org/10.1254/jpssuppl.96.0_3-b-p-232","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jpssuppl.96.0_3-b-p-232","pdf_url":"https://www.jstage.jst.go.jp/article/jpssuppl/96/0/96_3-B-P-232/_pdf","source":{"id":"https://openalex.org/S4210239061","display_name":"Proceedings for Annual Meeting of The Japanese Pharmacological Society","issn_l":"2435-4953","issn":["2435-4953"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceedings for Annual Meeting of The Japanese Pharmacological Society","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1254/jpssuppl.96.0_3-b-p-232","doi":"https://doi.org/10.1254/jpssuppl.96.0_3-b-p-232","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jpssuppl.96.0_3-b-p-232","pdf_url":"https://www.jstage.jst.go.jp/article/jpssuppl/96/0/96_3-B-P-232/_pdf","source":{"id":"https://openalex.org/S4210239061","display_name":"Proceedings for Annual Meeting of The Japanese Pharmacological Society","issn_l":"2435-4953","issn":["2435-4953"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceedings for Annual Meeting of The Japanese Pharmacological Society","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4313199044.pdf","grobid_xml":"https://content.openalex.org/works/W4313199044.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2047912959","https://openalex.org/W2058604897","https://openalex.org/W4241408471","https://openalex.org/W4388069137","https://openalex.org/W271618781","https://openalex.org/W2091608501","https://openalex.org/W2052079302","https://openalex.org/W2082113217","https://openalex.org/W3101210777","https://openalex.org/W1872946855"],"abstract_inverted_index":{"Amphetamine":[0],"metabolite":[1],"p-hydroxyamphetamine":[2],"(p-OHA)":[3],"has":[4],"been":[5],"shown":[6],"to":[7],"have":[8,23],"many":[9],"pharmacological":[10],"effects,":[11],"including":[12],"causing":[13],"psychostimulant-induced":[14],"behaviors":[15],"such":[16],"as":[17],"hyperlocomotion":[18],"and":[19,35,56,97],"head-twitch":[20],"response.":[21],"We":[22],"previously":[24],"reported":[25],"that":[26,124],"p-OHA":[27],"induces":[28],"prepulse":[29],"inhibition":[30],"(PPI)":[31],"disruptions":[32,38,63,71],"in":[33,41,60,64,131],"mice,":[34],"the":[36,42,50,53,125],"PPI":[37,62,70,133],"are":[39],"involved":[40,130,137],"dopaminergic":[43],"system.":[44],"In":[45],"this":[46],"study,":[47],"we":[48],"investigated":[49],"involvement":[51],"of":[52,138],"serotonin":[54],"(5-HT)":[55],"noradrenaline":[57],"(NA)":[58],"neurotransmission":[59,127],"p-OHA-induced":[61,69,132],"mice.":[65],"As":[66],"a":[67],"result,":[68],"were":[72,105],"attenuated":[73,107],"by":[74,108],"pretreatment":[75,109],"with":[76,110,135],"ketanserin":[77],"(a":[78,83,89,93,99,112,117],"5-HT2A/2C":[79],"receptor":[80,86,102],"antagonist),":[81,87,103],"MDL100,907":[82],"selective":[84,100],"5-HT2A":[85],"5,7-dihydroxytryptamine":[88],"5-HT":[90,94,126],"neurotoxin),":[91,114],"p-chlorophenylalanine":[92],"synthesis":[95,119],"inhibitor)":[96],"prazosin":[98],"\u03b11":[101,139],"but":[104],"not":[106],"DSP-4":[111],"NA":[113,118],"fuzaric":[115],"acid":[116],"inhibitor).":[120],"These":[121],"results":[122],"suggest":[123],"is":[128],"strongly":[129],"disruptions,":[134],"ancillary":[136],"receptors.":[140]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2023-01-06T00:00:00"}